Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Pharmacol Ther. 2013 Apr 30;139(3):313–326. doi: 10.1016/j.pharmthera.2013.04.013

Table 3.

Neurotransmitter Receptors in Microglia

Receptor Source Expression
A1 A2A; A2B; A3 rat/mouse primary proliferation, survival, cytokine, trophic effect
P2X1, P2X4, P2X7 rat brain sections Embryonic P2x1, P2X4; Adult P2X4; P2X7
P2X4 rat spinal cord Activated microglia/neuropathic pain
P2X7 primary/line/slice Activated microglia, cytokine release
P2Y2; P2Y6; P2Y12; P2Y13 Mouse primary Microglia activation, migration, pain
GluR1, GluR2, GluR3, GluR4 primary/cell line TNFα, cytoskeleton remodeling, chemotaxis
mGluR5a rat primary Ca2+ transient
mGluR2, mGluR4 rat primary TNFα, microglia activation
mGluR6, mGluR8 rat primary reduced neurotoxicity
GABAB(1a); b(1b); B(1c) rat/mouse primary/slice increased facial nerve axotomy microglia
α7 nACh rat/mouse primary nicotine triggered Ca2+ transients
α1A, α2A, β1, β2 rat primary cytokine release
Dopamine (D1, D2) rat/mouse primary/slice activated outward K+ currents
AMPA/KA primary only on proliferating microglia

Source indicates species and type of cell culture